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A Coronary Rupture in the Left Anterior Descending Artery at
Second Diagonal Artery Bifurcation Level in an Intervention with a
Tryton Side Branch Stent
MUHAMMED HAKAN TA , ZIYA SIMSEK, YAVUZER KOZA, ZAKIR LAZOGLU, EDNAN BAYRAM,
HUSEYIN SENOCAK
From Department of Cardiology, Faculty of Medicine, Ataturk University, Erzurum, Turkey
HAKAN TA ET AL.: A Coronary Rupture in the Left Anterior Descending Artery at Second Diagonal Artery
Bifurcation Level in an Intervention with a Tryton Side Branch Stent. Percutaneous coronary intervention (PCI)
for bifurcation lesions (BLs) is considered high risk due to increased procedural adverse events when compared to
non-bifurcation lesion. Dedicated bifurcation stents, specifically designed to allow minimally traumatic implantation
in the main vessel and/or side branch while providing adequate scaffolding of the side branch ostium may offer an
advantage over utilization of conventional stents. Coronary perforation as a complication of PCI is a rare but potentially
lethal complication that is associated with a high rate of morbidity. Coronary artery perforation during PCI has been
reported repeatedly. To our best knowledge perforation in a BL, PCI with the Tryton Side-Branch Stent has not been
reported. This case highlights that the Tryton to be an easy-to-use device in BLs, also operator should be careful, not
too aggressive, their potential risks should be born in mind and a graft stent must be available in catheterization
laboratory for emergencies. (J HK Coll Cardiol 2013;21:51-56)
Bifurcation lesion, Coronary rupture, Dedicated stent, Graft stent

PCI
Tryton

BLs
PCI
PCI

PCI
Tryton

Introduction
Bifurcation lesions (BLs) accounts for 15 to 20%
of percutaneous coronary interventions (PCI). 1,2
PCI for BLs is considered high risk due to increased
Address for reprints: Prof. Muhammed Hakan Ta
Department of Cardiology, Faculty of Medicine, Ataturk University,
Erzurum, Turkey
Email: mhakantas@gmail.com
Received July 19, 2013; revision accepted August 16, 2013
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procedural adverse events when compared to nonbifurcation lesions. Dedicated bifurcation stents,
specifically designed to allow minimally traumatic
implantation in the main vessel and/or sidebranch while
providing adequate scaffolding of the sidebranch ostium
may offer an advantage over utilization of conventional
stents. Previous Tryton registry studies have been reported
good clinical outcomes, but these studies are limited by
the small sample size and the relative short follow-up
period (6 months). In straight lesions, these stents have
been shown to provide good early and long term
results.3,4 Acute coronary artery perforation is a rare but
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challenging complication of PCI with hazardous
potential for the patient. It has been reported to occur
in 0.1 to 3.0% of patients undergoing PCI procedures.5
Coronary artery perforation during PCI has been
reported repeatedly. To our best knowledge perforation
in a BL with the Tryton Side-Branch Stent (Tryton
Medical, Inc., Newton, MA, USA) after kissing balloon
has not been reported.

Case
A 73-year-old male was admitted to our hospital
with recurrent angina with a period of four weeks. He
was an ex-smoker, hypertensive and dyslipidemic
patient under treatment with aspirin, clopidogrel,
β-blocker, angiotensin-converting-enzyme inhibitor and
statin. Two months ago a bare metal stent had implanted
to right coronary artery (RCA) because of inferior
myocardial infarction. On physical examination blood
pressure was 140/80 mmHg and pulse rate was 66 beats
per minute. He also had normal laboratory tests besides
elevated lipoprotein levels (predominantly high lowdensity lipoprotein). Patient underwent control coronary
angiography via right femoral artery which yielded
critical BL at the second diagonal level of the left
anterior descending artery (LAD) and 20% restenosis
in the stent of RCA (Figure 1A). We decided to implant
a Tryton stent to the BL. Patient informed consent was
taken. The LAD and second diagonal branch were wired
with Asahi Prowater (0.014 inch) and Asahi Sion blue
(0.014 inch), respectively (Figure 1B). A Tryton side
branch stent 3.0 x 2.5 mm was deployed in the second
diagonal artery at 10 atm pressure and another drugeluting stent (DES) (Abbott Xience V 2.75 x 23 mm;
Abbott Vascular Company, CA, USA) was deployed
main branch to the LAD at 10 atm pressure (Figures
1C-D). Kissing dilatation was performed at 12 atm
pressure with 2.5 x 25 mm Quqlimed Pyxis-C balloon
to the LAD and 2.5 x 15 mm Blue Medical Protege
balloon to the second diagonal branch (Figure 2A). This
led to the LAD perforation at the main branch zone of
the Tryton stent with contrast medium leaking into the
pericardial cavity (Figure 2B). Type C coronary rupture
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was visualized. Pericardiocentesis was not performed
because there was no evidence of cardiac tamponade.
The patient was still asymptomatic and
hemodynamically stable. A 2.75 x 23 mm Direct StentGraft (InSitu Technologies, Minnesota, USA) was
implanted at the bifurcation level of LAD at 12 atm
pressure (Figure 2C). After dye injection there was no
contrast medium leaking into the pericardium (Figure
2D,). After 15 minutes the patient complained from
severe angina. An acute thrombosis was seen in the graft
stent (Figure 3A). Tirofiban infusion with high dose
bolus regimen was started for 24 hours and than control
angiography was performed. The stents were patent
(Figure 3B). At first day echocardiographic controls
were made at every one hour. The patient was
hospitalized for six days and discharged with
medication.

Discussion
We report the successful management of a
perforation of the LAD because of BL stenting with
Tryton side branch stent. Coronary perforation as a
complication of PCI is a rare but lethal complication
that is associated with a high rate of morbidity.
According to the published reports, coronary perforation
occurs in 0.1-3.0% of all PCI cases and is associated
with a mortality rate of approximately 10% or higher.
Nevertheless, even if a provisional single-stent approach
is used, PCI of a BL is still associated with poorer
clinical outcomes when compared with PCI of a nonBL. Therefore, several dedicated bifurcation stents have
been developed to improve clinical outcomes of BLs
after PCI. One of these devices is the Tryton Side-Branch
Stent (Tryton Medical, Inc., Newton, MA, USA) which
is used in combination with a conventional DES in the
main branch. The Tryton stent is a 5 or 6 Fr-compatible
balloon expendable cobalt-chromium slotted-tube baremetal stent. The stent consists of three zones: a distal
side branch zone, a transition zone at the carina and a
main branch zone. The distal side branch zone has a
design similar to a regular stent, scaffolding the side
branch. The central transition zone has specific
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Figure 1. Angiographic images of (A) Critical lesion at the LAD and second diagonal branch bifurcation. (B) LAD
and second diagonal branch were wired with Asahi Prowater and Asahi Sion blue. (C) Deployed Tryton side branch
stent in to the second diagonal artery (D) Deployed drug-eluting stent in the main branch to the LAD.
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Figure 2. Angiographic images of (A) After Tryton stent deployment; (B) Kissing dilatation; (C) Perforated
segment of LAD and the contrast medium leaking into the pericardial cavity; (D) Graft stent emplacement at the
bifurcation level of LAD and seal of the rupture and the absence of contrast medium leaking into the pericardium.
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Figure 3. Angiographic images of A: Acute thrombosis in graft stent. B: After tirofiban infusion patency of the
stents.

geometry of three elements which can be independently
deformed to accommodate the wide range of carinal
anatomy. The proximal main branch zone ('the collar')
consists of two wedding bands and has a minimal
amount of metal allowing easy delivery of a standard
work-horse DES. The stent delivery system has four
markers for optimal positioning of the stent.
In coronary perforation patient-related predictors
of increased risk include previous interventions of the
target vessel, prior myocardial infarction, female gender,
and advanced patient age.6 As anatomic and procedurerelated predictors of increased risk include severe vessel
calcification or pronounced vessel tortuosity, low lumen
diameter of the target vessel, a balloon-to-artery ratio
>1.3, and the use of atheroablative interventional
devices. 5,6 The use of oversized balloons is a very
important mechanism in the development of perforation.
Achievement of a greater luminal diameter after the
J HK Coll Cardiol, Vol 21

intervention is associated with a lower restenosis rate,
but carries a higher risk for perforation. In our case
patient's advanced age, mismatch between balloon
diameter and coronary artery diameter and the calcified
lesion structure were the reasons of the perforation. We
used 2.5 x 25 mm and 2.5 x 15 mm balloons for kissing
balloon dilatation the balloon to artery ratio was
aproximately 1.9 and higher than the 1.3. The proximal
main branch zone of the stent was the point of the
rupture. At this zone has a minimal amount of metal so
protective effect of stent for rupture was minimal.
There is no consensus on the optimal treatment
of patients with coronary perforation.6,7 Non-surgical
prolonged balloon inflation to induce intracoronary
thrombosis, implantation of (membrane-covered) stents,
coil embolisation, injection of polyvinyl alcohol, and
intracoronary administration of autologous blood have
been reported as treatment modalities.6-8 Although the
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use of graft stents is associated with good immediate
success rates, long-term results are disappointing due
to the high incidence of restenosis and/or late thrombotic
occlusions.7 In our case stent-graft used for treatment
of the coronary dissection but an acute thrombosis
occurred 15 minutes after stenting. This might be due
to excessive metal overload in the proximal portion of
the left anterior descending artery. Intracoronary
imaging with intravascular ultrasound or optical
coherence tomography would be useful but we could
not perform due to technical incompetence. Fortunately,
this problem resolved with a tirofiban infusion of high
bolus dose .
This case highlights that the Tryton to be an easyto-use device in BLs, also operator should be careful,
not too aggressive; potential risks of PCI to BLs should
be borne in mind and a graft stent must be available in
catheterization laboratory for emergencies.

Disclosure statement
The authors declare that they have no financial
relationships or conflicts of interest regarding the
content herein.
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ICSM, THE SEVENTEENTH ANNUAL SCIENTIFIC MEETING
ABSTRACTS
Abstracts for Invited Lectures:
IL1.
22q11.21 DELETION ASSOCIATED WITH SPORADIC
TETRALOGY OF FALLOT IN HAN CHINESE
GW He,1,2,3 CL Maslen,3 XY Bai,1 XC Liu,1 ZG Liu,1 Q Yang1,4
TEDA International Cardiovascular Hospital, Tianjin, China; 2The Affiliated
Hospital, Hangzhou Normal University, Hangzhou, China; 3Heart Research
Center, Oregon Health & Science University, Portland, Oregon, 97239, USA;
4
Department of Medicine & Therapeutics, Chinese University of Hong Kong,
Hong Kong
1

Results: Deletion of 22q11.21 was seen in 8/60 (13.3%) cases. However, the
deletion was seen in different patterns in those patients, shown by different
starting and ending loci and involving genes. Parents of TOF probands with
a disease-associated CNV provided with ability to determine if any of the
CNVs were inherited or de novo. The CNVs were de novo mutations for all
these cases.
Conclusions: 22q11.21 deletion is associated with sporadic tetralogy of Fallot
in Han Chinese involving a large number of genes and the related individual
genes warrant further detailed investigations.

Purpose: Tetralogy of Fallot (TOF) is a congenital cardiac malformation
that consists of an interventricular communication, also known as a ventricular
septal defect, obstruction of the right ventricular outflow tract, override of
the ventricular septum by the aortic root, and right ventricular hypertrophy.
Overall it is the most common cause of cyanotic cardiac disease in infants.
In the United States TOF occurs in approximately one in 3,000 live births
and accounts for 10% of all serious congenital heart disease. However, studies
suggest that the incidence in TOF is substantially higher in China. This study
was designed to investigate the genetic basis of TOF in Han Chinese.
Methods: Genomic DNA was extracted from peripheral blood for each index
patient and control subject. Affymetrix genome-wide human SNP array 6.0
was used. Each array has 1,800,000 genetic markers, including more than
906,600 single nucleotide polymorphisms (SNPs) and more than 946,000
probes for the detecting copy number variations (CNVs). DNA was extracted,
amplified and hybridized to an Affymetrix Genome-Wide human SNP array
6.0. Copy number was calculated based on probe hybridization signal intensity
data relative to the signal of disease-free normal controls. To determine CNV
status on each sample we performed real-time PCR. TaqManTM probes
designed by the manufacturer (Applied Biosystems, Foster City, CA) were
used to target each of the specific region. The RNase P was chosen as the
reference gene.

IL3.
ADVANCES IN HYPERTENSION MANAGEMENT AND NEW
GUIDELINES UPDATE
NY Chan
Princess Margaret Hospital, Hong Kong
Hypertension is a prevalent disease worldwide with an estimated prevalence
of 30-45% in the European countries. In a recent community survey involving
803 Hong Kong citizens, the prevalence of hypertension was 32%, with a 28%
rise compared to similar surveys performed in 2011 and 2012. Apart from the
high disease burden, the high prevalence of organ damage in patients with
hypertension calls for extra attention. In a recently performed study involving
55 hypertensive patients followed up in Princess Margaret Hospital in Hong
Kong, 66% of patients had a carotid intima media thickness ≥75th percentile
and 26% of patients had carotid plaques respectively. There have been new
evidence on several diagnostic and therapeutic aspects of hypertension and
consequently, the recently released management guidelines on hypertension
differ in many aspects from the previous one. The new management guidelines
will be discussed in details with special emphasis on (1) asymptomatic organ
damage and its prognostic significance; (2) initiation of antihypertensive
treatment for high normal blood pressure; (3) treatment target for patients with
different cardiovascular risk; (4) choice of monotherapy, combination therapy
and fixed-dose single-pill combination; (5) treatment in elderly patients and
(6) new therapeutic options for drug-refractory hypertension.
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IL4.
RECENT ADVANCES IN THE MANAGEMENT OF HEART
FAILURE
CM Yu
Faculty of Medicine, Chinese University of Hong Kong, Hong Kong
Management of heart failure has gained significant success in the last 2 decades.
There has been significant progress in medical therapy exemplified by the
cocktail of neurohormonal blockers and device therapy. In managing heart
failure, device therapy had been at the forefront of non-pharmacological therapy.
It starts with the introduction of cardiac resynchronization therapy (CRT), a
pacing therapy that includes a left ventricular lead to improve synchronous
contraction of the heart. The therapy was initially targeting NYHA Class III
and IV patients with EF<35% and with a wide QRS complex. With the evolution
of this therapy from clinical evidence, this therapy now also extended to NYHA
class II patients. Although patient with a narrow QRS complex (<120 ms) was
demonstrated to have systolic dyssynchrony, in a recent multicenter trial, CRT
did not result in improvement of heart failure event in this population. For
medical therapy, our current study focuses on the prediction of lack of favorable
medical therapy in heart failure patients with systolic dysfunction. This includes
the potential role of biomarkers which are linked to the pathophysiologic
changes of heart failure. Furthermore, activation or suppression of certain
microRNAs might also play a role in heart failure progression, such as adverse
histopathological changes, which was being explored in our recent study
program. Lastly, the incorporation of echocardiographic imaging may add
further strength in the prediction of heart failure treatment response. These
findings may hope to triage patient therapy and design effective treatment
program. In prevention of HF, optimal control of cardiovascular risk factors

has been advocated in the guideline (e.g. hypertension and other risk factors
for atherosclerosis). Medical therapy for asymptomatic left ventricular
dysfunction has also been advocated. However, there is another phenomenon
which had drawn attention recently, which is the electromechanical delay caused
by pacing related-induced LBBB. This phenomenon commonly happened in
patients received right ventricular apical pacing. We had conducted the first
randomized, controlled, multicentre trial which showed that CRT is able to
prevent adverse remodeling of the left ventricle induced by right ventricular
apical pacing. Currently, long-term follow up study is underway to determine
if this therapy will prevent heart failure development.

IL5.
BIDIRECTIONAL NATURE OF CARDIOVASCULAR AND
KIDNEY DISEASE
K Shimizu
Cardiovascular Division, Nangai Clinic, National Medical Center, Saitama
Medical School, Japan

congestive heart failure. Whether differences in CVD in CKD patients suggest
preventative or therapeutic strategies unique to this population remains
unclear. Randomized controlled clinical trials must confirm the effectiveness
of current pharmacological and interventional therapies modifying traditional
and novel cardiovascular risk factors in patients at each stage of CKD, with
or without unique co-morbidities.

Cardiovascular disease (CVD) is the principal cause of morbidity and
mortality in patients with chronic kidney disease (CKD). CKD promotes
hypertension and dyslipidemia. Hypertension and diabetes causes
nephrosclerosis and diabetic nephropathy, leading to the progression of renal
failure. These traditional cardiovascular risk factors can promote CVD
development. In addition, inflammatory mediators such as cytokines,
chemokines, adhesion molecules, fibroblast growth factor 23, homocysteine,
or reactive oxygen species are often elevated and the renin-angiotensin system,
endothelin, and the sympathetic nervous system are frequently activated in
patients with CKD, accelerating atherosclerosis and/or left ventricular
hypertrophy. Mineral dysregulation accompanied by reduction of vitamin D,
hyperphosphatemia, and hyperparathyroidism in CKD patients promotes
vascular calcification associated with end-stage renal disease. Accelerated
atherosclerosis then leads to increased prevalence of coronary artery disease,
peripheral arterial disease, arterial stiffness, left ventricular hypertrophy, and
cerebrovascular disease. On the other hand, renal dysfunction can result from
diminished renal perfusion secondary to low cardiac output in left ventricular
failure, peripheral arterial disease, and atherosclerosis and increased renal
vasoconstriction mediated by neurohormonal and autonomic activation. Thus,
traditional and non-traditional cardiovascular risk factors serve as
cardiovascular and kidney risk factors. Consequently, kidney and
cardiovascular dysfunction bidirectionally promote chronic renal failure and
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IL6.
TRPC3 IN CORONARY ENDOTHELIAL FUNCTION: ROLE
OF HYPOXIA-REOXYGENATION AND HYPERKALEMIA
Q Yang, JH Huang, XQ Yao, CM Yu
Division of Cardiology, Department of Medicine and Therapeutics & Institute
of Vascular Medicine, Chinese University of Hong Kong, Hong Kong
Canonical transient receptor potential channels (TRPCs) have been considered
as the most important Ca2+-permeable cation channels in vascular endothelium
physiology. Our previous studies in porcine coronary arteries have
demonstrated that exposure to hypoxia-reoxygenation (H-R) or hyperkalemic
cardioplegic solutions impair endothelial function. eNOS-NO dysfunction
and compromised EDHF responses are mechanisms underlying the
impairment. Recently, we studied the role of TRPC3 in endothelial NO
production and EDHF responses with further investigations of the effects of
H-R and hyperkalemic/hyperkalemic cardioplegic solutions on this channel.
Our results showed that Ca2+ influx via TRPC3 significantly contributes to
NO release. The reduction of NO during H-R is associated with the
suppression of TRPC3 activity and the inhibition of TRPC3-mediated Ca2+
influx in coronary endothelial cells. TRPC3 is also involved in EDHF
response. Hyperkalemic exposure reduced TRPC3-mediated Ca2+ influx in a
concentration-dependent manner. Hyperkalemic cardioplegic solutions that
are commonly used in clinical practice such as St. Thomas Hospital (ST),
Histidine-Tryptophan-Ketoglutarate (HTK), and University of Wisconsin
(UW) solutions also reduced Ca 2+ influx in coronary endothelial cells.
Activation of TRPC prevented the reduction of Ca2+ influx in cells exposed
to solutions containing mild to moderate high concentration of K + .
Furthermore, the EDHF response compromised by hyperkalemic or

hyperkalemic cardioplegic solutions was restored by addition of TRPC
activator in the solution. These data suggests that inhibition of TRPC3 by
high concentration of K+ is a mechanism underlying the detrimental effect of
hyperkalemia on EDHF-mediated endothelial function. Taken together,
TRPC3 may represent a potential target for endothelial protection in hypoxic/
ischemic-related cardiovascular diseases and in open heart surgery.
(Supported by grants from Research Grant Council of Hong Kong (GRF
CUHK4774/12M) and National Natural Science Foundation of China
(81200123)).

IL7.
HUMAN CARDIAC TISSUE FABRICATED FROM HUMAN
EMBRYONIC STEM CELLS (hESCs): PRESENT STATUS AND
POTENTIAL APPLICATIONS
CW Kong
Stem Cell & Regenerative Medicine Consortium (SCRMC) and Department
of Physiology, LKS Faculty of Medicine, The University of Hong Kong, Hong
Kong
Impairment and loss of cardiomyocytes (CMs) due to aging or
pathophysiological conditions (e.g., myocardial infarction and chronic
hypertension) are generally considered irreversible, and can lead to
conditions from cardiac arrhythmias to heart failure. Human pluripotent stem
cells (hPSCs), including the embryonic stem cell (ESC) and induced
pluripotent stem cell (iPSC), can self-renew while maintaining their
pluripotency to differentiate into all cell types, including CMs. Indeed,
various directed differentiation protocols are available and dishes of hPSCCMs are now readily available from laboratories around the world. The lack
of appropriate human heart model to more closely simulate the normal and
pathophysiology of our native human heart is, however, a major roadblock
for further advancement. Novel bio-engineering and bio-nanofabrication
approaches to construct 3D human heart tissue and chambers as more
sensitive, accurate and high-throughput tools for disease modelling, drug
discovery and cardiotoxicity screening as well as transplantable bio-devices
and prototypes investigating currently will be discussed.
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A-FABP IS A POTENTIAL MEDIATOR OF DIABETIC
CARDIOMYOPATHY AND ISCHEMIC REPERFUSION
INDUCED CARDIAC INJURY
RLC Hoo
Department of Medicine, LKS Faculty of Medicine, The University of Hong
Kong
Diabetes increases the risk of heart dysfunction by inducing cardiomyopathy.
We have demonstrated that serum levels of adipocyte fatty acid-binding protein
(A-FABP), a fat-derived adipokine, increased significantly in patients with
heart failure and are independently associated with the deterioration of heart
function. We here describe the role of A-FABP in the pathogenesis of diabetic
cardiomyopathy and myocardial ischaemia/reperfusion (MI/R) induced cardiac
injury. A-FABP knockcout (KO) mice and their wild-type (WT) littermates
were employed in this study. The mRNA abundance and protein expression
levels of A-FABP in heart tissue were markedly elevated after MI/R injury
and streptozocin (STZ)-induced diabetes in WT mice. After MI/R, myocardial
infarct size, apoptotic index and superoxide production were alleviated in
A-FABP KO mice which accompanied by improved left ventricular function
compared with WT mice in either non-diabetic or diabetic groups.
Immunofluorescence staining showed that A-FABP was co-localized with
endothelial marker CD31. eNOS phosphorylation and NO production in the
heart tissue were significantly decreased in WT mice after MI/R while elevated
in that of A-FABP KO mice after MI/R injury and STZ-induced diabetes.
Diabetes-induced myocardial hypertrophy and fibrosis were also significantly
alleviated in A-FABP KO mice. In conclusion, A-FABP protects mice against
diabetic cardiomyopathy and myocardial ischemia/reperfusion induced cardiac
injury, which may through inducing eNOS phosphorylation and NO production
in the heart tissue.
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OP1.
TRPM2 CONTRIBUTES TO NEOINTIMAL HYPERPLASIA IN
VASCULAR WALLS
X Ru, 1 Y Huang, 1 Y Mori,2 X Yao1
Li Ka Shing Institute of Health Science and School of Biomedical Sciences,
Chinese University of Hong Kong, Hong Kong; 2Department of Synthetic
Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto
University, Kyoto, Japan
1

A hallmark of atherosclerosis is progressive intimal thickening (or neointimal
hyperplasia). Over-production of reactive oxygen species and alteration of
Ca2+ signaling are among the key factors contributing to the progression of
neointimal hyperplasia. In the present study, we investigated the role of
TRPM2, a ROS-sensitive Ca2+ entry channel, in neointimal hyperplasia.
Perivascular cuffs were used to induce neointimal hyperplasia in rodent
arteries. Immunostaining showed numerous TRPM2-postive smooth muscle
cells (SMCs) in neointimal regions. The neointimal hyperplasia was reduced
in Trpm2 knockout mice compared to wild-type mice. In cultured rodent
aortic SMCs, H2O2 treatment stimulated SMC proliferation and migration.
The effect of H 2O 2 was reduced by TRPM2-specific blocking antibody
TM2E3, 2-aminoethoxydiphenyl borate and Trpm2 knockout. These data
suggest a key functional role of TRPM2 in neointimal hyperplasia.

OP2.
BONE MORPHOGENIC PROTEIN 4 SUPPRESSION
PROTECTS ENDOTHELIAL FUNCTION IN TYPE 2
DIABETIC MICE
Y Zhang, J Liu, XY Tian, L Wang, JY Luo, WT Wong, Y Huang
Institute of Vascular Medicine, Li Ka Shing Institute of health Sciences, Chinese
University of Hong Kong, Hong Kong
Objective: Bone morphogenic protein 4 (BMP4) is involved in the progression
of vascular dysfunction in hypertension. Yet, its role in endothelial dysfunction
in type 2 diabetes remains unknown. This study aims to investigate whether
suppression of BMP4 can protect endothelial function in type 2 diabetic mice,
and to study the mechanism underlying BMP4-induced oxidative stress in
diabetes.
Methods: Type 2 diabetic db/db mice were utilized as animal model. In in
vivo experiments, the level of BMP4 in the arteries was inhibited by noggin
via osmotic pump infusion (1 µg·h-1·kg-1, 2 weeks) and also by BMP4 silencing
with BMP4-shRNA adenovirus (Ad-BMP4 shRNA) transduction via tail vein
injection (109 pfu/mouse). In ex vivo experiments, isolated mouse aortic rings
were cultured in medium containing BMP4 inhibitors, Ad-BMP4 shRNA
and BMP receptor 1a (BMPR1a) shRNA lentiviral particles. Vasoreactivity
was examined on wire myograph and pressure myograph. Reactive oxidative
species (ROS) in aortic endothelium and in cultured endothelial cells were
measured by dihydroethidium (DHE) staining, CM-H2DCFDA fluorescence
and chemilumininescence. Protein expression was determined by Western
blotting.
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Results: Noggin treatment and Ad-BMP4 shRNA transduction improved
impaired endothelium-dependent relaxations (EDRs) in aortae and mesenteric
arteries of db/db diabetic mice in both in vivo and ex vivo experiments.
Suppression of BMP4 reduced the over-production of ROS in db/db mouse
aortae, in ex vivo cultured C57BL/6 mouse aortae and primary mouse aortic
endothelial cells (MAECs) treated with high glucose (30 mmol/L). BMPR1a
silencing improved EDRs in db/db mouse aortae, and inhibited ROS
production in the endothelial layer. The suppression of BMP4-BMPR1a
signaling diminished BMP4 over-generation under hyperglycemic condition.
Conclusion: Inhibition of BMP4/BMPR1a axis restored endothelial function
in diabetic mice through reducing oxidative stress in the endothelium.
Attenuation of BMP4 signaling could be a potential therapeutic strategy
against diabetic vascular dysfunction. (Supported Hong Kong RGC-CRF
grant)
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OP3.
OXIDATIVE STRESS INDUCED BY INTERMITTENT
HYPOXIA EXACERBATES LIPID ACCUMULATION AND
INFLAMMATION IN A CELL MODEL OF NON-ALCOHOLIC
STEATOHEPATITIS (NASH)
JF Pan,1 R Guo,2 EC Liong,2 GL Tipoe,2 ML Fung1
Departments of 1Physiology and 2Anatomy, Li Ka Shing Faculty of Medicine,
The University of Hong Kong, Hong Kong
Background/Aims: The prevalence of obstructive sleep apnea (OSA) is high
in patients with non-alcoholic fatty liver disease (NAFLD) and NASH is a
progressive hallmark of the pathogenesis of NAFLD. Chronic intermittent
hypoxia is associated with recurrent episodes of oxygen desaturation and
reoxygenation in OSA patients, leading to excessive production of reactive
oxygen species (ROS). The causal link between OSA and NAFLD is not
known and the mechanistic effect of intermittent hypoxia (IH) on the
pathogenesis of NAFLD remains elusive. Here we tested the hypothesis that
IH-induced oxidative stress aggravates lipid accumulation and inflammation
induced by sodium palmitate in HepG2 cells.
Materials and Methods: HepG2 cells were treated with sodium palmitate
or vehicle under normoxia (Nx) or IH condition for 72 hours in the present
or absence of a ROS scavenger MnTBAP. Cell viability was detected by
MTT assay and intracellular lipid deposit was examined by oil red staining.
Lipid peroxidation was measured by malondialdehyde (MDA) assay and
levels of reactive oxygen species (ROS) were detected by CM-H2DCFDA
staining. The expressions of pro-inflammatory cytokines (IL-1β, TNF-α,
IL-6), fatty acid uptake-associated genes (caveolin-1 and FATP5), fatty acid
synthesis genes (SREBP1 and ACC1) and fatty acid β-oxidation gene ACOX
were determined by real-time PCR.

Results: Results showed that sodium palmitate increased lipid deposit in the
cells and it also decreased cell viability. The effect of sodium palmitate was
more prominent in the group co-treated with hypoxia. Levels of MDA and
ROS and the expressions of IL-1β, TNF-α, IL-6 and caveolin-1, but not
FATP5, were significantly increased in the palmitate- or hypoxia-treated
group and were remarkably elevated in the co-treated group. These effects
were abolished by MnTBAP treatment. In addition, levels of the expression
of ACOX, SREBP1 and ACC1 were significantly lowered in the cells treated
with palmitate or hypoxia and the expressions were much less in the cotreated group. Treatment of MnTBAP prevented the decreased expression of
ACOX but had no effect on the SREBP1 and ACC1 expression.
Conclusion: IH-induced oxidative stress exacerbates lipid accumulation and
inflammation induced by sodium palmitate in HepG2 cells, probably mediated
by an increase in lipid uptake and a decrease in the fatty acid β-oxidation.

OP4.
ROLE OF PROSTAGLANDIN E RECEPTOR SUBTYPE 4 (EP4)
IN THE REGULATION OF TRIGLYCERIDE METABOLISM
Y Cai, PM Vanhoutte, EHC Tang
Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine,
The University of Hong Kong, Hong Kong
Objectives: Hypertriglyceridemia is strongly associated with future risk of
insulin resistance, diabetes and cardiovascular disease. Interestingly, it has
been recently demonstrated that mice lacking cyclic AMP-responsive
element-binding protein H (CREB-H) showed higher plasma triglyceride
concentrations compared to wild-type mice. As an upstream stimulating factor
of CREB-H, prostaglandin E receptor subtype 4 (EP4) may participate in the
regulation of triglyceride metabolism. Thus, we tested whether or not deletion
of EP4 influences triglyceride metabolism, and if so, to explore the underlying
mechanisms.
Methods: EP4 wild-type and knockout mice were put on a high-fat diet (HFD)
for thirty weeks and changes in plasma triglycerides were monitored. The
impact of EP4 deletion on the ability to synthesize hepatic very low density
lipoprotein (VLDL)-triglyceride (TG) and intestinal chylomicron (CM)-TG,
as well as the ability to clear TG during HFD was examined. Lipoprotein
lipase (LPL) activity and mRNA expression of LPL and CD36 in brown
adipose tissue (BAT) were determined by fluorometric assay kit and
quantitative polymerase chain reaction (Q-PCR), respectively.
Results: After thirty weeks of high-fat diet, EP4 knockout mice had a higher
plasma TG level than wild-type mice. The deletion of EP4 did not influence
hepatic VLDL-TG production or intestinal CM-TG synthesis but impaired
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TG clearance rate. EP4 knockout mice had a decreased mRNA expression
and activity of LPL in their BAT, suggesting impaired hydrolysis and uptake
of triglycerides in this tissue. Moreover, EP4 knockout mice had a reduced
expression of CD36 in BAT, which may indicate that the uptake of fatty
acids is impaired.
Conclusions: Deletion of EP4 in high-fat fed mice resulted in
hypertriglyceridemia. The hypertriglyceridemia that accompanies EP4
deficiency is the result of impaired TG clearance, attributed to reduced mRNA
expression of LPL and CD36, and impaired LPL activity in BAT. The results
indicate that EP4 plays a critical role in systemic lipid homeostasis.
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OP5.
CIGARETTE SMOKING INDUCED OXIDATIVE STRESS IN
RAT HEART
YM Liang,1 MSM Ip,1,3 JCW Mak1,2,3
Departments of 1Medicine and 2Pharmacology & Pharmacy; 3Research Centre
of Heart, Brain, Hormone and Healthy Aging, The University of Hong Kong,
Hong Kong
Objectives: Cigarette smoking is known to be one of the important risk factors
for the development of cardiovascular disease. Despite the suggestion that
cigarette smoke (CS), a complex mixture of chemicals including more than
4,000 components, affects several known pathophysiological pathways, such
as oxidative stress, inflammation, and endothelial dysfunction, leading to
the development of athero-thrombosis; however, little is known about the
underlying mechanisms. To investigate the role of CS as a risk factor for
cardiovascular disease, we assessed the changes in oxidative stress markers
in heart tissues after CS exposure.
Methods: Male Sprague-Dawley rats (aged 6-7 weeks) were randomly divided
into two groups, as sham air (SA) group (n=8) and CS group (n=8)
respectively. The CS group was exposed to 4% CS for 1h each day for 56
days in ventilated smoking chambers, while the SA group was exposed to
fresh air. Animals were sacrificed 24 h after the last exposure and heart tissues
were collected. Heart homogenates were prepared for the determination of
level of advanced oxidation protein products (AOPP, a protein oxidation
marker) by spectrophotometric detection method and enzyme activity of
superoxide dismutase (SOD) by using commercial assay kit. The expression
of endothelial nitric oxide synthase (eNOS) was also determined by Western
blot analysis.

Results: CS exposure caused significant elevation of cardiac AOPP level
(p<0.05), suggesting the presence of protein oxidation in CS-induced
oxidative damage in rat heart. In addition, cardiac SOD activity was
significantly reduced after exposure to CS (p<0.01), indicating the imbalance
between oxidants and anti-oxidants in the heart. We also found CS-induced
inhibition of eNOS phosphorylation in heart homogenates.
Conclusions: All these data provide evidences for the potential contribution
of CS to endothelial dysfunction and thus to cardiovascular disease due to
the existence of oxidative stress in the heart of CS-exposed rat.
(This study is supported by Hong Kong RGC General Research Fund (HKU
774410M)).

OP6.
SIRT1 PROTECTS AGAINST OBESITY AND AGEING
INDUCED ENDOTHELIAL DYSFUNCTION VIA
ENHANCING BROWN-REMODELING OF PERIVASCULAR
ADIPOSE TISSUE (PVAT)
HXY Hui, P Gu, A Xu
Department of Medicine and Pharmacology, The University of Hong Kong,
Hong Kong
Background and objective: SIRT1 is a key molecule controlling adipose
tissue browning. Our previous study has demonstrated that perivascular
adipose tissue (PVAT) plays a pivotal role in determining endothelial function.
However, the exact function of SIRT1 in PVAT is unknown. The aim of the
present study is to investigate whether SIRT1 elicits a protective role toward
obesity and ageing-associated endothelial dysfunction.
Methods: Adipose-specific SIRT1 knockout mice (AKO) were generated
by crossing SIRT1 flox mice with a-fabp-Cre mice. The SIRT1 flox mice
were used as the wild type control (WT). The mice were fed with either
standard chow for 1 year or high fat high cholesterol diet for 12 weeks followed
by exposure to 4oC for 6 days. The aortic rings with or without PVAT were
subjected to wire myograph to examine the acetylcholine induced vascular
relaxation. The adiponectin level was measured by qPCR or
immunohistochemistry.
Results: The WT and AKO mice exhibited similar endothelial function under
obese and ageing conditions. However, in the presence of PVAT,
acetylcholine induced relaxation was impaired in obese and ageing AKO
mice, suggesting that SIRT1 within PVAT plays an essential role in
antagonizing against obesity and ageing-associated vascular dysfunction.
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Moreover, PVAT displayed a switch from brown toward white phenotype
upon obese and ageing conditions. To further establish a correlation between
brown phenotype in PVAT with its vascular-modulating function, WT and
AKO mice were acclimated to cold temperature for 6 days before the aortic
relaxation was examined. The results showed in WT mice, the brown
phenotype in PVAT was readily enhanced by cold exposure. Meanwhile,
cold acclimation led to improved vascular function in the presence of PVAT.
In contrast, AKO mice were resistant to cold-induced brown remodeling and
improvement of vascular function. Additionally we found cold exposure
increased adiponectin expression in WT mice, but not in AKO mice.
Conclusion: The brown phenotype in PVAT is related to a protective function
of PVAT under obese and ageing conditions and SIRT1 was a key factor in
controlling brown phenotype in PVAT. Adiponectin represents the possible
link between PVAT browning and its function.

October 2013

J HK Coll Cardiol, Vol 21

ICSM, THE SEVENTEENTH ANNUAL SCIENTIFIC MEETING
ABSTRACTS
Abstracts for Oral Presentation:
OP7.
CONNEXIN-HEMICHANNELS ARE INVOLVED IN
ACIDOSIS-INDUCED ATP RELEASE FROM SKELETAL
MYOCYTES
L Lu, J Tu, HJ Ballard
Department of Physiology, The University of Hong Kong, Hong Kong
ATP is an important extracellular signalling molecule which contributes to
exercise vasodilation. We have previously shown that the cystic fibrosis
transmembrane conductance regulator (CFTR) is involved in acidosis-induced
ATP release from skeletal muscle. However, it is still unknown whether ATP
is released through CFTR itself or whether CFTR regulates a separate ATPrelease channel. So we investigated: (1) the pathway responsible for CFTR
activation in myocytes at low pH; (2) whether connexin (Cx) hemichannels
were involved in the acidosis-induced ATP release from skeletal muscle.
Lactic acid (10 mM) increased the intracellular cAMP and the extracellular
ATP in L6 skeletal myocytes. Similarly, the cAMP-elevating agent, forskolin,
increased extracellular ATP. The phosphodiesterase inhibitor, IBMX,
increased extracellular ATP in the absence or presence of lactic acid. CFTR
phosphorylation was increased by the addition of forskolin alone, and further
increased by forskolin plus dibutyryl-cAMP and IBMX, but the forskolininduced increase in CFTR phosphorylation was inhibited by the PKA inhibitor,
KT5720. Whereas KT5720 inhibited acidosis-induced ATP release from
myocytes. These data suggest that skeletal muscle CFTR is activated through
the cAMP/PKA pathway at low pH. RT-PCR indicated that cultured rat L6
skeletal myocytes expressed mRNA for both Cx40 and Cx43, but Cx40 was
expressed only weakly in western blot, whereas Cx43 was strongly expressed.
Co-immunoprecipitation results showed that CFTR and Cx43 were associated
with each other in the cell membrane. A Cx43 over-expression model was

created by transfecting myocytes with a Cx43 plasmid: Cx43 over-expression
was confirmed using western blot. Cx43 over-expressing myocytes released
significantly more ATP than control myocytes at pH 6.8, suggesting that
Cx43 may be involved in acidosis-induced ATP release, whereas silencing
Cx43 expression using siRNA inhibited the acidosis-induced ATP release.
Over-expression of CFTR alone did not alter ATP release from myocytes,
whereas co-over-expression of CFTR with Cx43 increased ATP release
significantly more than over-expression of Cx43 alone. These data suggest
that Cx43 co-localises with CFTR in the myocyte membrane, and that it
may be involved in ATP release during acidosis; further investigation is
required to determine whether and how CFTR interacts with Cx43 to induce
ATP release.

OP8.
COMPARISONS OF MEASURED AND SELF-REPORTED
ANTHROPOMETRIC VARIABLES AND BLOOD PRESSURE
IN A SAMPLE OF HONG KONG ADULT WOMEN
YJ Xie,1 S Chan Ho2
1
Division of Epidemiology and Biostatistics, School of Public Health,
The University of Hong Kong; 2Division of Epidemiology, The Jockey Club
School of Public Health and Primary Care, Chinese University of Hong Kong,
Hong Kong
Objectives: To assess the validity of self-reported weight, height, waist
circumference and blood pressure by comparison with measured values in a
sample of Hong Kong adult women, and to determine the extent of
misclassification of body mass index (BMI) arising from differences between
self-reported and measured values.
Methods: This pilot study was integrated in a life course study named "Hong
Kong Women's Health Study" in 1253 Hong Kong female nurses aged from
35 to 65 years. A mailed self-administered questionnaire was used to collect
data. The validity of self-reported weight, height, waist circumference and
blood pressure was examined by inviting 144 (11.5%) participants to have
their body measurements at the research centre according to the standard
measurement protocol. The measured values were compared with their selfreported values to assess the validity.
Results: On average, there was a high correlation between the self-reported
and measured anthropometric and blood pressure values (correlation
coefficients ranged from 0.72 to 0.96). No significant differences were found
between self-reported and measured weight and blood pressure values (all
P>0.05). However, women tended to overestimate their height (mean
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difference between self-reported and measured height: 0.42 cm, P<0.05)
and underestimate their waist circumference (mean difference between selfreported and measured: 1.61cm, P<0.05). The Kappa consistency tests all
showed good consistency between the categories of the self-reported and
measured BMI, waist circumference and blood pressure values, percentage
of overall agreement ranging from 60% to 100%. The use of self-reported
weight and height resulted in the correct classification of weight status in
85% of women.
Conclusion: We suggest that the self-reported height, weight, waist
circumference and blood pressure measures were generally reliable in this
population of Hong Kong female nurses. However it is still important to
carefully consider potential biases in the interpretation of data when using
self-reported indicators in epidemiological studies.
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CP1.
PPARδ
δ INVOLVES IN THE VASCULAR BENEFITS OF
METFORMIN IN OBESE MICE
WS Cheang, XY Tian, WT Wong, Y Huang
Li Ka Shing Institute of Health Sciences and School of Biomedical Sciences,
Chinese University of Hong Kong, Hong Kong
Objectives: Anti-diabetic drug metformin is known to activate AMP-activated
protein kinase (AMPK) which forms a transcriptional complex with PPARδ
and synergistically induces gene expression. The present study investigated
whether PPARδ is a critical mediator for metformin in ameliorating
endothelial dysfunction in diet-induced obese (DIO) mice.
Methods: Aortae from C57BL/6J mice were cultured with endoplasmic
reticulum (ER) stress inducer tunicamycin, metformin, PPARδ antagonist
GSK0660, PPARδ agonist GW1516 or AMPK inhibitor compound C. Male
PPARδ wild-type and knockout mice were fed with high-fat diet for 3 months
to induce obesity, followed by oral administration with metformin for one
week. Vascular reactivity and protein levels were determined by wire
myograph and Western blotting respectively. Levels of reactive oxygen
species (ROS) and nitric oxide (NO) were measured by fluorescence imaging.
Results: Tunicamycin impaired endothelium-dependent relaxations (EDR)
in response to acetylcholine, and increased the levels of ROS and ER stress
markers, such as phosphorylated eIF2α, ATF6 and ATF3 in mouse aortae.
These harmful effects of tunicamycin were reversed by co-treatment with
metformin while such benefits of metformin were abolished by GSK0660.
GW1516 exerted similar beneficial effects as metformin but the benefits
were unaffected by compound C. Chronic metformin treatment alleviated

EDR and reduced the levels of ROS and above-described ER stress markers
in DIO PPARδ wild-type but not in PPARδ knockout mice. NO production
in endothelial cells was also enhanced by metformin.
Conclusions: The present study provides novel evidence that PPARδ is a
crucial mediator in the vascular benefits of chronic metformin treatment in
restoring the impaired endothelial function and curtailing ER and oxidative
stress in obese mice (under revision for publication in Atherosclerosis,
Thrombosis, and Vascular Biology).

CP2.
INTERLEUKIN-6 IMPAIRS ENDOTHELIUM-DEPENDENT
DILATATIONS IN MOUSE ARTERIES THROUGH
INCREASING OXIDATIVE STRESS
D Qu, J Liu, CW Lau, Y Huang
Institute of Vascular Medicine and Li Ka Shing Institute of Health Sciences,
Chinese University of Hong Kong, Hong Kong
Objective: Interleulin-6 (IL-6) is one of major pro-inflammatory cytokines
involved in chronic inflammation, hence contributing to the pathogenesis
of diabetes, atherosclerosis and other cardiovascular diseases. The plasma
level of IL-6 rises in response to infection, vascular injury, and exercise as
well. IL-6 secretion is not restricted to cells of the immune system, but also
occurs in many other types of cells, including endothelial cells and vascular
smooth muscle cells. Nevertheless, whether IL-6 is beneficial or deleterious
in the vascular system remains debated. The present study investigates how
IL-6 impacts on endothelial function in both conduit and resistance mouse
arteries and its relevance in vascular pathogenesis.
Methods and results: Both DHE staining of mouse aortic endothelial cells
and en face imaging of mouse aortae show that IL-6 (1 ng/ml) stimulates the
production of reactive oxygen species (ROS) which reaches its maximum at
1 hour, and can be diminished by ROS scavengers, vitamin E and tempol.
The ROS generation is also confirmed by chemiluminesence assay. The acute
effect of IL-6 on vasoreactivity of aortae and small mesenteric arteries from
C57BL/6 mice was examined. Arterial rings were suspended in wire myograph
or pressure myograph for measurement of isometric force or vessel diameter.
One-hour acute treatment with IL-6 (1 ng/ml) attenuates acetylcholine-

68

induced endothelium-dependent relaxations in aortas, and impairs flowmediated dilatation of 2nd-order resistance mesenteric arteries. Such
impairment can be reversed by ROS scavengers. Moreover, IL-6 stimulates
ROS increase through NADPH oxidases. Finally, IL-6 treatment reduces nitric
oxide production stimulated in primary mouse aortic endothelial cells.
Conclusion: IL-6 acutely impairs endothelial function in mice likely through
stimulating ROS generation and thus reducing the NO bioavailability.
(Supported Hong Kong GRF and CRF)
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MECHANISTIC EFFECTS OF LYCIUM BARBARUM
POLYSACCHARIDES AGAINST RAT HIPPOCAMPAL
INJURIES INDUCED BY CHRONIC INTERMITTENT
HYPOXIA
CS Lam,1 GL Tipoe,2 RCC Chang,2 KF So,2 KH Cheung,1 ML Fung1
Departments of 1Physiology and 2Anatomy, The University of Hong Kong,
Hong Kong
Background: Chronic intermittent hypoxia (CIH), highlighting clinical
manifestations of obstructive sleeping apnea (OSA), induces oxidative stress,
inflammation, endoplasmic reticulum (ER) stress and apoptosis in
hippocampus in which regenerative mechanism is subsequently activated
for repairing damages. Lycium barbarum polysaccharides (LBP), bioactive
fraction of traditional Chinese herbal medicine Goji, are demonstrated to
possess anti-oxidative and anti-inflammatory properties, and promote
hippocampal neurogenesis inhibited by corticosterone.
Objectives: Our study aims to elucidate the mechanistic effects of LBP in
CIH rats. We hypothesize that LBP attenuate oxidative stress, inflammation,
endoplasmic reticulum stress, apoptosis, and facilitate hippocampal
regeneration in rat exposed to CIH.
Methods: Adult Sprague-Dawley rats (180-200 g) were exposed to air as
normoxic control (Nx) or to intermittent hypoxic treatment (IH) with
normobaric oxygen content alternating between 5 to 21% 8 hr/day for 1 week.
Rats were orally fed LBP solution (1 mg/kg body weight) or vehicle 2 hours
prior to hypoxic treatment. Lipid peroxidation extent was measured by MDA
assay. Western blot was employed to examine the expressions level of
antioxidant enzymes (SOD-1, SOD-2, GPx-1); inflammatory mediators
(IL-1β, TNFα, COX-2); redox sensitive transcriptional factor Nuclear factor

kappa B (NFκB) p65 and p50; negative regulator of NFκB (IκBα); ER stress
markers (GRP78/Bip, PERK and CHOP); caspase-dependent extrinsic
(FADD, caspase 8, Bid) and intrinsic apoptotic (Bax, Bcl2, cytochrome C)
cell death (cleaved caspase 3) cascades; endogenous cell cycles markers
(PCNA); phosphorylation of survival molecule Akt (p-Akt(Ser 473)). In situ
cell death staining (TUNEL) was utilized to reveal the apoptotic situation of
hippocampal subfields (DG, CA1 and CA3). PCNA and BrdU DAB
immunostaining were performed to demonstrate cellular proliferation in
subgranular zone (SGZ) of dentate gyrus in hippocampus.
Results: LBP administration significantly decreased and restored,
respectively, the elevated MDA level and depleted antioxidant enzymes in
the hypoxic treated group. Besides, degradation of IκBα, activation and
translocation of NFκB p65 and p50 were observed in hypoxic treated groups
but were significantly inhibited by LBP pre-treatment. Additionally, LBP
pre-treatment markedly attenuated ER stress sensors activated in hypoxic
treated groups. The number of TUNEL positive labelled cells was found
significantly increased when compared with that of controls but dramatically
reduced by LBP pre-treatment. Importantly, LBP antagonized CIH-induced
hippocampal cell death through mitigation of caspase mediated intrinsic and
extrinsic cascades. On the other hand, the numbers of PCNA- and BrdUpositive labelled cells were elevated in hypoxic groups and were further
augmented by LBP administration. Consistently, protein levels of PCNA
and phosphorylated Akt were increased in the hypoxic group, which were
further enhanced by LBP pre-treatment.
Conclusion: The anti-oxidant, anti-apoptotic and pro-regenerative properties
of LBP could explain its protective effects against neurocognitive deficit
induced by severe OSA conditions.

CP4.
EFFECTS OF ADVANCED GLYCATION ENDPRODUCTS
ON ADRENOMEDULLIN GENE EXPRESSION IN
MACROPHAGES
HK Wong, RYH Leung, BMY Cheung
Department of Medicine, The University of Hong Kong, Hong Kong
Objectives: Oxidative stress can stimulate adrenomedullin (ADM) secretion
and mRNA expression. One source of oxidative stress comes from the
formation of advanced glycation endproducts (AGEs) from glycation reaction
stimulated by hyperglycemia. This study aims to investigate whether AGEs
affect ADM expression in rat macrophage cells.
Methods: Rat macrophage NR8383 cells were grown to confluence before
experiments. The cells were stimulated by AGEs, bovine serum albumin
(BSA), AGEs plus exogenous ADM or saline. The dose response and time
response of AGEs treatment was investigated. Cells were harvested and RNA
was extracted for measurement and analysis of ADM gene expression.
Results: ADM gene expression increased by an average of 16.5% after 6
hours, but the increase was independent of AGEs doses (P=0.715). Within 4
hours of AGEs treatment there was a significant trend of gene expression
increase with time (P<0.01). The increase was the greatest upon 1-hour
treatment by 67.8%. However the changes in ADM gene expression were
not significantly different from those found with control treatments.
Conclusions: AGEs has no significant effect on ADM gene expression in
this model, therefore the relationship between AGEs on ADM expression is
yet to be proven.
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INVOLVEMENT OF AUTOPHAGY IN THE EFFECT OF
EXERCISE ON LEFT VENTRICULAR HYPERTROPHY
INDUCED BY HIGH FAT DIET IN RATS
F Wu,1 R Guo,2 JF Pan,1 GL Tipoe,2 ML Fung1
Departments of 1Physiology and 2Anatomy, The University of Hong Kong,
Hong Kong
Objectives: Left ventricular hypertrophy (LVH) associated with obesity
increases the morbidity and mortality of cardiovascular disease, which could
be attenuated by exercise in overweight and hypertensive patients. The
lysosomal degradation pathway − autophagy is reportedly mediated the
beneficial effect of exercise on glucose and lipid homeostasis. The present
study aimed to investigate the involvement of autophagy in the effect of
exercise on LVH induced by high fat diet in rats.
Methods: Female adult SD rats were divided into 4 groups namely: (i) high
fat diet (HFD), (ii) HFD+exercise, (iii) exercise, (iv) control. Rats in the
HFD groups were orally fed with high-fat chow (30% fat) daily for 12 weeks,
and rats in the exercise groups had exercise with a motorized wheel in the
last 4 weeks. Noninvasive measures of systolic pressure and fat composition
were assessed, respectively by tail cuff and MRI. The expression of markers
for cardiac hypertrophy and the protein expression in autophagic pathway
were determined by quantitative real time-PCR and western blot, respectively.
Statistical significance was at p<0.05 with ANOVA analysis followed by
post-hoc tests.
Results: Rats fed with HFD had LVH (increased heart weight and LV/
RV+septum ratio) with higher levels of body weight, arterial pressures and
fat composition than that of the control rat. In addition, the QTc interval and

the diameter and disarray of ventricular myocytes were significantly
increased in the HFD group, supported by elevated levels of the expression
of hypertrophic markers (ANP, BNP, β-MHC). These parameters were
attenuated by exercise in the HFD-fed rats. Moreover, we found elevated
levels of LC3II in the HFD heart, which were also attenuated by exercise,
suggesting an involvement of autophagy in the beneficial effect of exercise.
Furthermore, the expression level of AMPKα was also increased in the
exercise groups.
Conclusion: We demonstrated that exercise lowers the body weight and
attenuates the HFD-induced LVH in rats, which probably involves autophagy.
Future studies will focus on the role of autophagy in the pathogenesis.

CP6.
THE FUNCTIONAL ROLE OF TRPV4 CHANNELS IN
BARORECEPTOR SENSITIVITY
EOC Lau, CY Lo, Y Huang, X Yao
School of Biomedical Sciences, Chinese University of Hong Kong,
Hong Kong

Consistently, the stretch-induced [Ca2+]i rise could be inhibited by RN1734,
which is a potent TRPV4 channels blocker. Taken together, these results
suggest that the difference in pressure sensitivity between the aortic and
carotid baroreceptor neurons was probably brought about by TRPV4
channels, which are stretch-activated channels.

There are two major arterial baroreceptors that can detect blood pressure
change in the arteries. They are the aortic (arch) baroreceptor and carotid
(sinus) baroreceptors. Aortic baroreceptor detects blood pressure in the aorta.
Carotid baroreceptor detects blood pressure in carotid artery, which carries
the blood to the brain. Reports suggest that there are differences between
these two baroreceptors in terms of their pressure sensitivity and functional
role. But the results are controversial. In the present study, the properties of
the two baroreceptors were investigated. It was found that aortic baroreceptor
neurons were more sensitive to pressure change than carotid baroreceptor
neurons. Electrophysiology studies showed that, compared to the carotid
baroreceptor neurons, a higher percentage of aortic baroreceptor neurons
were stretch-sensitive. Furthermore, the pressure threshold that can initiate
action potential firing was found to be lower in the aortic baroreceptor
neurons than in the carotid baroreceptor neurons. Uniaxial stretch-induced
[Ca2+]i rise was compared between aortic and carotid baroreceptor neurons.
Again, the aortic baroreceptor neurons were found to be more sensitive to
stretch than the carotid baroreceptor neurons. Immunostaining experiments
revealed that, compared to carotid baroreceptor neurons, a much higher
percentage of aortic baroreceptor neurons were TRPV4-positive.
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SALVIANOLIC ACID B IMPROVED ENDOTHELIUMDEPENDENT RELAXATIONS IN DIABETIC DB/DB MICE
AORTAS

κB
ANTI-INFLAMMATORY EFFECT OF miR-17-3P VIA NF-κ
PATHWAY IN HUMAN ENDOTHELIAL CELLS

J Liu,1 J Han,2 HN Zhang,1 Y Huang1
1
School of Biomedical Sciences, Chinese University of Hong Kong, Hong
Kong; 2Tasly Microcirculation Research Center, Peking University Health
Science Center, Beijing, China
Objective: Diabetes is a world-wide health problem and cardiovascular
disease is the leading cause of death and disability in diabetic patients.
Danshen Dripping pills is widely used in China for the treatment of cardiac
angina, coronary artery disease and other vascular events. But the underlying
mechanism is still unclear. The major ingredients of Danshen Dripping Pills
are found to be Salvianolic acid B (SAB) danshensu and protocatechuic
aldehyde, among which SAB is believed to account for a substantial part of
the vascular benefit. However how SAB improves vascular function remains
poorly understood. The present study aims at examining the effect of SAB
against diabetic vasculopathy and the possible cellular mechanism involved.
Methods: Twelve-week old db/db diabetic mice were orally administrated
with SAB for one week and then sacrificed. The aortae were dissected out
for both functional and molecular studies.
Results: Acetylcholine-induced endothelium-dependent relaxations were
impaired in db/db mice compared with non-diabetic db/m + mice. SAB
treatment improved the impaired endothelial function in db/db mice and this
improvement was accompanied with suppressed C-jun N-terminal kinase
phosphorylation.
Conclusion: Both in vivo and ex vivo treatment with SAB alleviate diabetic
endothelial dysfunction in db/db mice and this finding highlights the
therapeutic potentials of SAB-containing herbs against diabetic vasculopathy.

Y Zhang, SWS Leung, RYK Man
Department of Pharmacology & Pharmacy, The University of Hong Kong,
Hong Kong
Objective: MicroRNAs (miRNAs) are a class of small, noncoding RNAs of
≈22 nucleotides that negatively regulate gene expression. They appear to
play a role in the development/progression of many disorders, including
inflammation, cardiovascular diseases and endothelial dysfunction. This study
examines the role of miR-17-3p in vascular inflammation.
Methods: Human umbilical vein endothelial cells (HUVECs) were
transfected with miR-17-3p agomir (miR-17-3p mimic) or its negative control
using lipofectamine 2000. They were incubated with lipopolysaccharide (LPS,
10 ng/ml) for 16 hours to induce inflammatory reactions. The level of miR17-3p and the expressions of IκBα, p65 and phosphorylated p65 (p-p65) were
measured by qPCR and Western blotting. The amount of interleukin-8
(IL-8) and tumor necrosis factor (TNF)-α released in the culture medium
was detected with ELISA kit.
Results: The levels of miR-17-3p, IL-8, TNF-α and p-p65 were increased
following LPS stimulation. While the expression of p65 was not changed,
the expression of IκBα was reduced. LPS-induced increase in IL-8 level and
decrease in IκBα expression were smaller in HUVECs transfected with miR17-3p agomir than in those transfected with the negative control.

CP9.
PERIVASCULAR ADIPOSE TISSUE (PVAT) INDUCES
ENDOTHELIAL DYSFUNCTION VIA PRODUCTION OF
SUPEROXIDE
P Gu, HXY Hui, A Xu
Department of Medicine and Pharmacology, The University of Hong Kong,
Hong Kong

endothelial function induced by DIO. After 6 days exposure to 4oC, DIO
mice showed decreased superoxide production within PVAT and the EDR
was also improved in aorta with PVAT.
Conclusion: PVAT has anti-relaxation effect to aorta and this effect is further
enhanced in obesity which in turn induces endothelial dysfunction via
increased production of superoxide.

Background and objective: Perivascular adipose tissue (PVAT) has been
shown to produce vasoactive substances and regulate vascular tone. The aim
of this study is to investigate whether obesity induces endothelial dysfunction
via PVAT and elucidate the underlying mechanisms.
Methods: Six-week-old C57BL/6J mice were fed with either standard chow
or high fat, high cholesterol diet for 12 weeks. The obese mice were exposured
to cold environment (4oC) for 6 days. The aortic rings either without or with
PVAT were isolated and the endothelial-dependent relaxation (EDR) of aorta
in response to acetylcholine was measured by wire myograph. The superoxide
production of PVAT was determined by DHE staining and lucigenin assay.
Results: The EDH was reduced in the presence of PVAT, demonstrating
that PVAT elicits an anti-relaxation effect to blood vessel. Following that,
we sought to investigate whether this anti-relaxation activity was changed
under obese condition. The EDR of aorta without PVAT were not different
between lean and obese mice. However, in the presence of PVAT, the
relaxation was significantly impaired in aortic artery from obese mice,
suggesting obesity was accompanied by a more prominent anti-relaxation
activity in PVAT. PVAT from obese mice showed increased superoxide
production while the superoxide scavenger Tiron partially recovered impaired
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DO UNSATURATED FATTY ACIDS HAVE BENEFICIAL
EFFECT ON REDUCTION OF STROKE RISK IN
HYPERTENSIVE POPULATION?
H Peng,1 XQ Cai,2 TK Tsang,3 HS Shen,4 XH Wu,2 YB Zhou,2 C Li,5
BMY Cheung5
1
Department of Epidemiology, School of Public Health, Medical College of
Soochow University, Suzhou, China; 2Department of Laboratory Medicine;
4
Department of Surgical Oncology, Kunshan Affiliated Hospital of Nanjing
University of Traditional Chinese Medicine, Suzhou, China; 3School of Public
Health; 5Department of Medicine, The University of Hong Kong, Hong Kong
Background: It has been suggested that monospecific unsaturated fatty acids
have potential effect on protection against stroke. Studies on the effect of
different categories of fatty acids are lacking. The stroke incidence is high in
hypertensive patients. Therefore, we studied the relationship between serum
level of 6 categories of fatty acids and stroke incidence in hypertensive patients.
Methods: 89 pairs including 100 men and 78 women matched by sex and
age were recruited and analyzed in this study. We allowed age discrepancy
within 5 years in each pair. All the patients aged from 34 to 85 years old
were diagnosed with hypertension or had an average (mean of 3) blood
pressure ≥140/90 mm Hg. The fatty acids used for internal standard solution
were obtained from Sigma, US. All the patient serum fatty acids were
methylated before concentration determination. Each concentration
determination was repeated twice and percent recovery was estimated.
Univariate analysis was used to identify potential confounders in the
relationship between serum levels unsaturated fatty acids and stroke incidence.
Conditional logistic regression for matched pair data was used to adjust for
potential confounders and classical risk factors for stroke.

Results: Comparing participants with or without history of stroke, there
were differences in educational level (P=0.002) and occupation (P<0.001).
Participants without history of stroke had higher levels of total cholesterol
(P<0.001), triglyceride (P=0.041), LDL (P=0.048) and HDL (P=0.001)
compared with those with history of stroke. All the levels of 6 fatty acids
were higher in participants without history of stroke compared with those
with history of stroke (P=0.017 for palmitoleic acid, 0.001 for palmitic acid,
<0.001 for linoleic acid, <0.001 for behenic acid, <0.001 for nervonic acid
and 0.002 for lignoceric acid). Before adjustment, the stroke incidence was
inversely associated with the levels of fatty acids except lignoceric acid
(P=0.160). After adjustment for education and occupation, the levels of
palmitoleic acid (P=0.102) and palmitic acid (P=0.094) were no longer
inversely associated with the stroke incidence. After further adjustment for
systolic blood pressure, smoking, drinking, total cholesterol and triglyceride,
the inverse associations of linoleic acid (OR=0.965, 95%CI=0.942-0.990,
P=0.005), behenic acid (OR=0.778, 95%CI=0.664-0.939, P=0.009), nervonic
acid (OR=0.323, 95%CI=0.121-0.860, P=0.024) with stroke incidence were
still highly significant.
Conclusion: In this cross-sectional study, the levels of all the fatty acids
except lignoceric acid were inversely associated with the stroke incidence.
Our results raise the possibility that unsaturated fatty acids may have
beneficial effect on reduction of stroke risk in hypertensive population.

CP11.
VITAMIN D PROTECTS VASCULAR FUNCTION IN DIETINDUCED OBESE MICE
Z Gao, HN Zhang, J Liu, WS Cheang, L Wang, Y Huang
Institute of Vascular Medicine and School of Biomedical Sciences, Chinese
University of Hong Kong, Hong Kong
The health benefits of vitamin D are increasingly recognized. Vitamin D
protects the cardiovascular function although the detailed cellular mechanisms
remain largely unclear. Our previous study demonstrates an endothelial cell
protective benefit of calcitriol, an active form of vitamin D in arteries from
hypertensive rats and humans and in estrogen-deficient rats.
Objectives: This study aims at investigating the potential beneficial effects
of calcitriol in high fat diet-induced obese mice.
Methods: Glucose metabolism and insulin sensitivity were tested by oral
glucose and insulin tolerance test. Acetylcholine-induced endotheliumdependent relaxation (EDR) in aortae were measured by wire myograph,
flow-dependent vasodilatations in resistance mesenteric arteries were
measured by pressure myograph. Fluorescence imaging determined the levels
of reactive oxygen species (ROS) in human umbilical vein endothelial cell
(HUVEC) under confocal microscope.
Results: After four-month feeding on high fat diet, mice became obese with
impaired metabolic and vascular function. Four-week treatment with
calcitriol via intraperitoneal injection improves glucose metabolism and
insulin sensitivity, restores the impaired EDR in response to acetylcholine
in aortas and flow-dependent vasodilatations in resistance mesenteric arteries
of obese mice. This benefit is accompanied by marked reduction in the level
of reactive oxygen species (ROS) in the vascular wall and in endothelial
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cells. Ex vivo study demonstrates that calcitriol can reverse ROS production
induced by endoplasmic reticulum (ER) stress inducer and high glucose
(30 mM) in HUVEC and this effect is antagonized by selective human vitamin
D receptor antagonist, TEI-9647. Calcitriol also rescues the endothelial
function that is impaired by ER stress inducer.
Conclusions: We thus provide the first line of evidence that calcitriol is
effective in restoring both metabolic and vascular functions in obese mice,
adding additional health benefit of vitamin D.
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BMP4 UPREGULATES PDGF-AA EXPRESSION:
RELEVANCE TO ENDOTHELIAL DYSFUNCTION

NITRIC OXIDE AND PROTEIN KINASE G ACTS ON TRPV4TRPC1-KCa1.1 COMPLEX TO INHIBIT 11,12-EET-INDUCED
VASCULAR VASCULAR RELAXATION

WN Hu, JY Luo, L Wang, CW Lau, Y Huang
Institute of Vascular Medicine and Li Ka Shing Institute of Health Sciences,
Chinese University of Hong Kong, Hong Kong

P Zhang, Y Ma, X Ma, XQ Yao
School of Biomedical Sciences, Chinese University of Hong Kong,
Hong Kong

Bone morphogenetic protein 4 (BMP4) stimulates superoxide anion production
and exerts pro-inflammatory effects in blood vessels. However, the underlying
mechanisms by which BMP4 mediates endothelial dysfunction, hypertension
and diabetes remain partly understood. The platelet-derived growth factors
(PDGFs) and their receptors (PDGFRs) are major angiogenic regulators and
are involved in arteriosclerosis, hypertension and diabetes, although their
relations to BMP4 signaling are unclear. The present study shows that BMP4
treatment up-regulates the expression of PDGF-AA and PDGFRα in human
umbilical vein endothelial cells, which was reversed by the BMP4 antagonist
noggin and ROS scavenger, tiron plus DETCA. Furthermore, PDGF-AA can
stimulate ROS generation in endothelial cells and in mouse arteries as measured
by DHE fluorescence imaging and lucigenin fluorescence assay. Functional
studies show that treatment with PDGF-AA attenuates acetylcholine-induced
endothelium-dependent relaxations in mouse aortas and exaggerates
endothelium-dependent contractions in L-NAME-treated rat renal arteries.
Pharmacological inhibition with COX-2 and ROS ameliorates PDGF-induced
impairment of the relaxations. The present results indicate that ROS probably
mediates PDGF-induced harmful effects on endothelial function and PDGF
may be involved in BMP4-induced endothelial dysfunction. Since BMP4 is
one of the important common initiators of vascular dysfunction in hypertension
and diabetes, inhibiting PDGF-mediated actions in blood vessels might be
effective in helping control vascular events in hypertension and diabetes
(Supported by Hong Kong GRF and CRF).

Objective: To explore the mechanism of nitric oxide (NO) inhibition on
epoxyeicosatrienoic acids (EETs)-induced smooth muscle hyperpolarization
and relaxation.
Approach and Results: Co-immunoprecipitation studies demonstrated that
TRPV4 (vanilloid transient receptor potential channel 4), TRPC1 (canonical
transient receptor potential channel 1), and KCa1.1 (large conductance Ca2+activated K+ channels) physically interact with each other to form a TRPV4TRPC1-KCa1.1 complex in porcine coronary artery smooth muscle cells.
Arterial tension measurement and sharp microelectrode methods showed that
11,12-EET-induced membrane hyperpolarization and vascular relaxation were
markedly reduced by treatments that inhibit the activity of KCa1.1, TRPV4, or
TRPC1. S-nitroso-N-acetylpenicillamine (SNAP) and 8-Br-cGMP exert an
inhibitory influence on the 11,12-EET-induced membrane hyperpolarization
and vascular relaxation. The inhibitory action of SNAP and 8-Br-cGMP was
markedly reduced by treatments that suppress the protein kinase G (PKG)
phosphorylation on TRPC1. Similar results were also obtained in human
embryonic kidney 293 (HEK293) cells that over-expressed with TRPV4,
TRPC1 and KCa1.1.
Conclusions: This study uncovers a novel mechanism by which NO inhibits
the action of EETs. We found that NO-cGMP-PKG inhibits the 11,12-EETinduced smooth muscle cell hyperpolarization and vascular relaxation by acting
on the TRPC1 component within the TRPV4-TRPC1-KCa1.1 complex.

P03.

P04.

cGMP AND PROTEIN KINASE G REGULATE
HYPERTROPHY OF HUMAN EMBRYONIC STEM CELLDERIVED CARDIOMYOCYTES − POSSIBLE ROLE OF
ORAI1?

THE USE OF HEALTH BELIEF MODEL IN PROMOTING
CARDIOVASCULAR HEALTH

Y Wang, XQ Yao
Li Ka Shing Institute of Health Science and School of Biomedical Sciences,
Chinese University of Hong Kong, Hong Kong
Cardiac hypertrophy is initially compensatory, but it ultimately leads to heart
failure. An increasing amount of evidence suggests that cyclic guanosine 3',
5'-monophosphate (cGMP) and its effector kinase, protein kinase G (PKG),
play an important role in modulating cardiac hypertrophy and remodeling
and exert cardioprotective effect through the regulation of calcium handling
upstream. Store-operated calcium entry (SOCE) can be induced in
cardomyocytes and is a potential mechanism that is involved in cardiac
hypertrophy. ORAI1 is the pore-forming subunit of the calcium releaseactivated calcium (CRAC) channel. This prompts us to study the cGMP/
PKG regulation of SOCE/ORAI1 activity with respect to cardiac hypertrophy.
Human embryonic stem cell-derived cardiomyocytes (hESC-CMs) have great
promise for tissue repair and as a potential human-based in vitro
cardiomyocyte model system for studying cardiac physiology and
pathophysiology. The majority of hESC-CM initially resembles immature
human cardiomyocytes. However, the signaling pathways involved in their
growth have not yet been fully characterized. In this study, we will expose
hESC-CMs to hypertrophic stimuli such as phenylephrine (PE) to build
up a novel in vitro test system and focus on hypertrophic response of
hESC-CMs.
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Open University of Hong Kong, 2Tuen Mun Hospital, Hong Kong

1

Background: Medical models have been dominated in the treatment of
cardiovascular diseases. However, the application of medical models limited
the intertwining of various components of health such as socio-cultural factors.
Health Belief Model (HBM) has been widely applied as a conceptual
framework to study health behavior. It is a well-known model and has been
tested in many different situations. HBM is supported to explain the change
and maintenance of health behaviors. The objective of this study is to explore
the current literature in applying HBM in promoting cardiovascular health.
Methods: A systematic search on multiple databases was conducted using
keywords "health belief model", "cardiovascular", "heart", "cardiac". The
results were reviewed and summarized.
Results: The review of studies suggested that limited studies had applied
HBM in studying health behavior in promoting cardiovascular health. Majority
of the studies focused on promoting self-care of heart failure patients,
knowledge among individuals on cardiovascular health, medication adherence
of patients with cardiovascular diseases, the relationship between demographic
features and cardiovascular health, and preventive behavior among
individuals.
Conclusion: Although HBM is supported to be widely applicable in health
behavior studies. The result of this study addressed the limited use of HBM
in promoting cardiovascular health. In order to promote cardiovascular health,
the use of HBM as conceptual framework in further studies is suggested.
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EMP4 − A POTENTIAL POTASSIUM ION CHANNEL?

L Sun, YW Tjong, XQ Yao
Li Ka Shing Institute of Health Sciences and School of Biomedical Sciences,
Chinese University of Hong Kong, Hong Kong
Nonaspanins are characterized by a large N-terminal extracellular domain
and nine putative transmembrane domains. This evolutionarily conserved
family comprised four members in mammals. Human EMP4 protein, which
belongs to the superfamily member 4, has been found to be expressed in
human metastatic melanoma cells, where EMP4 play an important role in
tumour cannibal activity. EMP4 are also required for phagocytosis in S2
Drosophila cells. However, it is not clear which ion can pass through this
channel and its functional role in mammalian cells. To answer these
questions, we firstly examined the subcellular localization of human EMP4
protein in HEK293 cells and tissue distribution in rat. Then, whole-cell patch
clamp was applied to investigate its electrophysiological properties. Here,
we report some preliminary data. (1) Raising polyclonal antibodies against
human EMP4 derived from rabbit. (2) We found that EMP4 is abundantly
expressed in rat heart, kidney, liver and aorta tissues using western blot and
immunohistochemistry. (3) EMP4 is mainly localized in the late endosome
and Golgi body and a small part localized in early endosome in HEK293
cells by immunostaining. (4) Whole-cell currents were recorded in HEK293
cells. The results demonstrated that the over-expression of EMP4 resulted
in an electrical current, which was inhibited by a broad-spectrum K+ channel
inhibitor Ba 2+, but could not blocked by chloride channel blocker SITS,
suggesting that EMP4 could be a potential K+-selective ion channels. (5) In

order to visualize compartmentalized EMP4 activity in plasma membrane
microdomains, we targeted EMP4 to plasma membrane using different lipid
modification domains for further functional study. Overall, our data indicates
that EMP4 could be a potential potassium selective channel which mainly
localized in the late endosome and Golgi body in HEK293 cells and
abundance expression in kidney and heart. Further investigation needs to
do to explore its function.

P06.
INVOLVEMENT OF CALCIUM/CAMODULIN-DEPENDENT
KINASE II IN THE REGULATION OF VASCULAR TONE IN
PORCINE CORONARY ARTERIES
DKY Yeung, Q Pu, RYK Man, SWS Leung
Department of Pharmacology and Pharmacy, The University of Hong Kong,
Hong Kong
Objectives: Inhibition of calcium/calmodulin-dependent kinase II (CaMKII)
has been shown to reduce vascular contraction and relaxation. The present
study examined the role of CaMKII in the different signaling pathways
involved in the regulation of vascular tone.
Methods: Isolated porcine coronary arteries were incubated in organ chamber
for the measurement of isometric tension. They were contracted with
cumulative additions of contracting agents, potassium chloride and the
thromboxane A2 analogue, U46619, or contracted with U46619 (30 nM)
followed by cumulative additions of different relaxing agents, in the presence
or absence of the CaMKII inhibitor, KN-93.
Results: Inhibition of CaMKII by KN-93 (30 µM) significantly inhibited
contractions to potassium chloride (10-70 mM) and U46619 (0.1 nM-1 µM)
in porcine coronary arteries without endothelium. While endotheliumdependent nitric oxide (NO)-mediated relaxations to bradykinin (0.1 nM1 µM) were significantly inhibited by KN-93, endothelium-dependent
hyperpolarization (EDH)-mediated relaxations were not affected. On the
other hand, KN-93 inhibited endothelium-independent relaxations to
levcromakalim (adenosine triphosphate-sensitive potassium channel opener;
0.1 nM-100 µM), but not those to sodium nitroprusside (NO donor; 0.1 nM100 µM).
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Conclusions: Our data suggested that CaMKII in both the endothelium and
smooth muscle of porcine coronary arteries plays a role in the regulation of
vascular tone. In the smooth muscle, CaMKII contributes to contraction likely
via mechanisms downstream of increases in intracellular calcium
concentration. It is also involved in the activation of adenosine triphosphatesensitive potassium channels leading to vascular relaxation. In the
endothelium, CaMKII appears to play a role in the release of NO, but not the
induction of EDH, for relaxation. (This study was supported by the Small
Project Funding of the University of Hong Kong Research Grant).
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P07.
THE EFFECT OF ASTRAGALUS MEMBRANACEUS ON
PATHOLOGICAL ANGIOGENESIS
WY Liu,1 KKW Auyeung,2 JKS Ko,2 RYK Man,1 SWS Leung1
Department of Pharmacology and Pharmacy, Faculty of Medicine, The
University of Hong Kong; 2Center for Cancer and Inflammation Research,
School of Chinese Medicine, Hong Kong Baptist University, Hong Kong
1

HUVECs [under the stimulation of phorbol myristate acetate (PMA),
a protein kinase C activator] and HCT 116 cells by wound healing migration
assay and tube formation assay, in order to identify the influence of
astragalus membranaceus and its components on pathological angiogenesis.

Abnormality of angiogenesis can contribute to several pathologic processes
including atherosclerosis and cancer. Different bioactive components of
astragalus membranaceus (huangqi), a commonly used herb in traditional
Chinese medicine, exert different effects on the angiogenesis of human cancer
cells and endothelial cells. Therefore, the effect of astragalus membranaceus
and its active components on angiogenesis under different pathological
conditions were investigated. Human umbilical endothelial cells (HUVECs)
and human colon cancer cell HCT 116 were used for in vitro studies. The
effect of astragalus membranaceus on proliferation were examined using
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.
The results indicated that the viabilities of HUVECs treated with astragalus
saponin (0.1 to 25 µg/ml), astragaloside IV (0.01 to 100 µM) and calycosin
(1 to 200 µM) for 24-72 hours were not significantly different from the
control group (without any treatment). Astragalus saponin and astragaloside
IV, at the same concentrations as used in HUVECs, also did not affect the
viability of HCT 116 cells, while the highest concentration of calycosin
(200 µM) inhibited the growth of HCT 116 cells. The angiogenic potential
of these components of astragalus membranaceus are examined in both

P08.
IDENTIFICATION OF ALTERED PLASMA PROTEINS BY
PROTEOMIC STUDY IN VALVULAR HEART DISEASES AND
THE POTENTIAL CLINICAL SIGNIFICANCE
G Gao,1 C Xuan,2 Q Yang,1,3 XC Liu,2 ZG Liu,2 GW He1,4
1
TEDA International Cardiovascular Hospital & The Affiliated Hospital,
Hangzhou Normal University, Tianjin & Hangzhou, China; 2 TEDA
International Cardiovascular Hospital, Tianjin, China; 3Department of
Medicine & Therapeutics, Chinese University of Hong Kong, Hong Kong;
4
Department of Surgery, Oregon Health and Science University, Portland,
Oregon, U.S.A.
Objectives: Little is known about genetic basis and proteomics in valvular
heart disease (VHD) including rheumatic (RVD) and degenerative (DVD)
valvular disease. The present proteomic study examined the hypothesis
that certain proteins may be associated with the pathological changes in the
plasma of VHD patients.
Methods and Results: Differential protein analysis in the plasma identified
18 differentially expressed protein spots and 14 corresponding proteins or
polypeptides by two-dimensional electrophoresis and mass spectrometry in
120 subjects. Two up-regulated (complement C4A and carbonic anhydrase 1)
and three down-regulated proteins (serotransferrin, alpha-1-antichymotrypsin,
and vitronectin) were validated by ELISA in enlarging samples. The plasma
levels (n=40 for each) of complement C4A in RVD (715.8±35.6 vs. 594.7±
28.2 ng/ml, P=0.009) and carbonic anhydrase 1 (237.70±15.7 vs. 184.7±10.8
U/L, P=0.007) in DVD patients were significantly higher and that of
serotransferrin (2.36±0.20 vs. 2.93±0.16 mg/ml, P=0.025) and alpha-1antichymotrypsin (370.0±13.7 vs. 413.0±11.6 µg/ml, P=0.019) in RVD
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patients were significantly lower than those in controls. The plasma
vitronectin level in both RVD (281.3±11.0 vs. 323.2±10.0 µg/ml,
P=0.006) and DVD (283.6±11.4 vs. 323.2±10.0 µg/ml, P=0.011) was
significantly lower than those in normal controls.
Conclusions: We have for the first time identified alterations of 14 differential
proteins or polypeptides in the plasma of patients with various VHD. The
elevation of plasma complement C4A in RVD and carbonic anhydrase 1 in
DVD and the decrease of serotransferrin and alpha-1-antichymotrypsin in
RVD patients may be useful biomarkers for these valvular diseases. The
decreased plasma level of vitronectin − a protein related to the formation of
valvular structure − in both RVD and DVD patients might indicate the
possible genetic deficiency in these patients.

October 2013

75

List of Reviewers 2013
CHAN Ngai-Yin
KWOK On-Hing, Vincent
LEE Kang-Yin, Michael
LEE Lai-Fun, Kathy

76

October 2013

J HK Coll Cardiol, Vol 21

